| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2011.38.8819 |
| P698 | PubMed publication ID | 22253469 |
| P50 | author | Hans J van der Vliet | Q57051708 |
| Tanja D de Gruijl | Q90913412 | ||
| Hans Langendijk | Q110532414 | ||
| P2093 | author name string | Rik J Scheper | |
| Ruud H Brakenhoff | |||
| Alfons J M van den Eertwegh | |||
| C René Leemans | |||
| Henk M W Verheul | |||
| Johan W Molling | |||
| Famke L Schneiders | |||
| Renée C G de Bruin | |||
| P433 | issue | 5 | |
| P921 | main subject | head and neck squamous cell carcinoma | Q18348812 |
| P304 | page(s) | 567-570 | |
| P577 | publication date | 2012-01-17 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Circulating invariant natural killer T-cell numbers predict outcome in head and neck squamous cell carcinoma: updated analysis with 10-year follow-up | |
| P478 | volume | 30 |
| Q44851304 | Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses |
| Q26778648 | Antitumor Responses of Invariant Natural Killer T Cells |
| Q90259266 | CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond |
| Q36759287 | CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses |
| Q33815383 | Development of a qPCR method to rapidly assess the function of NKT cells. |
| Q92854724 | Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets |
| Q64100339 | Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review |
| Q39049093 | Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination |
| Q36054765 | Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features |
| Q43555934 | Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies |
| Q38734173 | Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression. |
| Q37702183 | Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy |
| Q42078314 | Natural Killer T Cells in Cancer Immunotherapy |
| Q52645931 | Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy. |
| Q42552126 | T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness |
| Q37995950 | Targeting natural killer cells and natural killer T cells in cancer |
| Q55094012 | The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach. |
| Q98205361 | The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy |
| Q34936375 | Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy. |
| Q39021436 | iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo . |
Search more.